EU Grants Marketing Authorization for Hyrimoz; Plus FDA Rejects New Drug Application for Buprenorphine Sublingual Spray Michele B. Kaufman, PharmD, BCGP | August 8, 2018In late July, the European Commission granted marketing approval for Hyrimoz, which is biosimilar to adalimumab…
